No Prescription |
 |
 | ||
|
Risofos Actonel |
|
| ||
No Prescription » Prescription Drugs 14 » Risofos Actonel Risedronate is used to treat a disease that weakens bones (Paget's disease). This medication helps to reduce bone pain and may prevent long-term complications from this disease. Risedronate works by slowing bone loss to help maintain strong bones and reduce the risk of breaks (fractures). It belongs to a class of medications called bisphosphonates.OTHER USES: This section contains uses of this drug that are not listed in the approved professional labeling for the drug but that may be prescribed by your health care professional. Use this drug for a condition that is listed in this section only if it has been so prescribed by your health care professional.This drug may also be used to prevent and treat certain types of bone loss (osteoporosis). Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases as you age after menopause or if you are taking corticosteroid medications (e.g. prednisone) for long periods of time.How to use Risedronate OralRead the Patient Information Leaflet provided by your pharmacist before you start using risedronate and each time you get a refill. Follow the instructions very closely to maximize the amount of drug absorbed and reduce the risk of injury to your esophagus. Consult your doctor or pharmacist if you have any questions.Take this medication by mouth after getting up for the day and before taking your first food beverage or other medication. Do not take it at bedtime or while you are still in bed.Take this medication with a full glass (6-8 ounces or 180-240 milliliters) of plain water. Do not take it with any other beverage. Swallow the tablet whole. Do not chew or suck on it. Then stay fully upright (sitting standing or walking) for at least 30 minutes and do not lie down until after your first food of the day. Wait at least 30 minutes after taking risedronate before you eat or drink anything other than plain water and before taking any other medication by mouth.Calcium or iron supplements vitamins with minerals antacids containing calcium/magnesium/aluminum dairy products (e.g. milk yogurt) and calcium-enriched juice may interfere with absorption of risedronate. Medications such as quinapril certain forms of didanosine (chewable/dispersible buffered tablets or pediatric oral solution) sucralfate and bismuth subsalicylate may also interfere with absorption. Do not take these products for at least 30 minutes after taking risedronate.Use this medication regularly in order to get the most benefit from it. For the treatment of Paget's disease remember to take it at the same time each morning usually for 2 months.Risedronate Oral is used to treat the following:Osteoporosis Decreased Bone Mass Following Menopause Post-Menopausal Osteoporosis Prevention Osteoporosis caused by Glucocorticoid Drugs Glucocorticoid-Induced Osteoporosis Prevention Paget's Disease of Bone Buy Risofos Actonel and other Prescription Drugs 14 products online at Medstore. Buy Online at Medstore - Click Here!
About Risofos Actonel: Product Type: Prescription Drugs 14 Risofos ( Actonel Generic Risedronate ) Risofos (Actonel Generic Risedronate) Actonel Generic Risedronate 150mg 9 Tablets 150mg 3 Tablets 150mg 6 Tablets 35mg 4 Tablets 35mg 12 (3 x 4 Tablets) 75mg 2 Tablets 75mg 6 (3 x 2 Tablets) Actonel Generic Risedronate Risofos
View more Prescription Drugs 14 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
